196 related articles for article (PubMed ID: 15760771)
1. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton.
Koay MA; Brown MA
Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of bone metabolism by pathogenic mutations and polymorphism in the LRP5-Wnt signaling genes].
Urano T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():95-100. PubMed ID: 18161089
[No Abstract] [Full Text] [Related]
3. The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.
Johnson ML
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):135-8. PubMed ID: 15615112
[TBL] [Abstract][Full Text] [Related]
4. [Wnt-beta-catenin signaling in bone metabolism].
Urano T
Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
[TBL] [Abstract][Full Text] [Related]
5. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
[TBL] [Abstract][Full Text] [Related]
6. [Wnt signaling and bone metabolism].
Asaba H; Sakai J
Clin Calcium; 2005 May; 15(5):813-8. PubMed ID: 15876744
[TBL] [Abstract][Full Text] [Related]
7. LRP5 and Wnt signaling: a union made for bone.
Johnson ML; Harnish K; Nusse R; Van Hul W
J Bone Miner Res; 2004 Nov; 19(11):1749-57. PubMed ID: 15476573
[No Abstract] [Full Text] [Related]
8. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification and functional characterization of Wnt signaling co-receptors LRP5 and LRP6.
Fleury D; Vayssiere B; Touitou R; Gillard C; Lebhar H; Rawadi G; Mollat P
Protein Expr Purif; 2010 Mar; 70(1):39-47. PubMed ID: 19716419
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling: a key regulator of bone mass.
Baron R; Rawadi G; Roman-Roman S
Curr Top Dev Biol; 2006; 76():103-27. PubMed ID: 17118265
[TBL] [Abstract][Full Text] [Related]
11. [Cytokines in bone diseases. Wnt signal and excessive bone formation].
Hosoi T
Clin Calcium; 2010 Oct; 20(10):1526-31. PubMed ID: 20890035
[TBL] [Abstract][Full Text] [Related]
12. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
[TBL] [Abstract][Full Text] [Related]
13. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
14. When the gut talks to bone.
Long F
Cell; 2008 Nov; 135(5):795-6. PubMed ID: 19041744
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines in bone diseases. Wnt signaling and osteoporosis-pseudoglioma syndrome].
Ozono K
Clin Calcium; 2010 Oct; 20(10):1520-5. PubMed ID: 20890034
[TBL] [Abstract][Full Text] [Related]
16. The Wnt signaling pathway and bone metabolism.
Johnson ML; Kamel MA
Curr Opin Rheumatol; 2007 Jul; 19(4):376-82. PubMed ID: 17551370
[TBL] [Abstract][Full Text] [Related]
17. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
[TBL] [Abstract][Full Text] [Related]
18. Lrp5 and bone formation : A serotonin-dependent pathway.
Yadav VK; Ducy P
Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
[TBL] [Abstract][Full Text] [Related]
19. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
[TBL] [Abstract][Full Text] [Related]
20. [Wnt/LRP5, a new regulation osteoblastic pathway involved in reaching peak bone masses].
Caverzasio J
Rev Med Suisse Romande; 2004 Feb; 124(2):81-2. PubMed ID: 15095618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
